
The safety profile of zzso in special populations was evaluated by analyzing data extracted from the database of phase zzso studies which included data on zzso zzso injections of which 119 in pediatric patients, zzso in elderly patients and 30 in patients with varying degrees of zzso impairment zzso severe or end stage requiring zzso zzso was administered at doses ranging from zzso zzso to zzso zzso and was found to be safe in all patient populations irrespective of age and of pre-existing zzso zzso There appeared to be no correlation between zzso of adverse events and dose level in these special populations and the higher dose level of zzso zzso could be safely administered also to patients with end stage zzso disease requiring zzso from whom the contrast medium was rapidly and efficiently zzso 

